C4 Therapeutics, Inc.
CCCC · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$105 | -$132 | -$128 | -$84 |
| Dep. & Amort. | $2 | $2 | $2 | $1 |
| Deferred Tax | $0 | $0 | $0 | $2 |
| Stock-Based Comp. | $30 | $27 | $30 | $22 |
| Change in WC | $8 | -$7 | -$17 | -$30 |
| Other Non-Cash | $1 | $3 | $7 | $2 |
| Operating Cash Flow | -$65 | -$107 | -$106 | -$87 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$2 | -$5 | -$1 |
| Net Acquisitions | $0 | $0 | -$64 | $188 |
| Inv. Purchases | -$284 | -$130 | -$220 | -$538 |
| Inv. Sales/Matur. | $233 | $290 | $283 | $350 |
| Other Inv. Act. | $0 | $0 | $64 | -$188 |
| Investing Cash Flow | -$51 | $158 | $58 | -$189 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | -$13 | $0 | $0 |
| Stock Issued | $44 | $58 | $1 | $169 |
| Stock Repurch. | -$0 | -$0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1 | $0 | $0 | $2 |
| Financing Cash Flow | $45 | $45 | $1 | $171 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$71 | $97 | -$46 | -$105 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $130 | $33 | $79 | $184 |
| End Cash | $59 | $130 | $33 | $79 |
| Free Cash Flow | -$65 | -$109 | -$111 | -$88 |